Karyopharm Therapeutics, Inc. (KPTI)
7.895
-0.86
(-9.77%)
USD |
NASDAQ |
Mar 12, 16:00
8.20
+0.30
(+3.86%)
After-Hours: 20:00
Karyopharm Therapeutics Total Assets (Quarterly) : 117.46M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Baxter International, Inc. | 20.06B |
| Bruker Corp. | 6.241B |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Agios Pharmaceuticals, Inc. | 1.297B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 410.38M |
| Shareholders Equity (Quarterly) | -292.93M |
| Debt to Equity Ratio | -0.7975 |
| Current Ratio | 1.120 |
| Net Debt Paydown Yield | -5.84% |